Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 2b7f6fabon Jan 23, 2024 10:18am
220 Views
Post# 35840715

RE:RE:RE:RE:What Do you Think

RE:RE:RE:RE:What Do you Think I would take the other side of that bet, this pp, if there is one, will raise more than $700,000.  BTD in first quarter and AA quickly thereafter.

Assuming big pharma isn't manipulating the FDA with regard to Theralase, then the FDA just wants to make sure the CR rates are legitimate before granting BTD and probably AA.  The FDA doesn't want to be embarrased granting AA and then later needing to retract.  I say accelerated approval soon because the data demonstrates the shrinking or elimination of tumors.  And the alternative drugs approved for bladder cancer seem to be not as affective.

riverrrow wrote: You've missed it, but at least one poster in the last few days  has said that Roger has invited them to participate in the current pp.  I'm going to guess this pp raises less than $700,000, so onwards to the next pp in March.   I'm constantly shocked that nobody with really deep pockets is onboard with TLT.  GLTA.



<< Previous
Bullboard Posts
Next >>